Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Heart Health: Hypertension medications recalled due to cancer risk | Wine & type 2 diabetes
Tuesday, March 29, 2022
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Editor's Choice: Heart Health

FDA announces recall of hypertension medications due to potential cancer risk

The voluntary recall includes quinapril HCl/hydrochlorothiazide tablets sold by Pfizer and authorized generics of that same medication. 

READ MORE >
These quinapril HCl/hydrochlorothiazide tablets, which Pfizer sells under the name Accuretic, are included in the voluntary FDA recall.
Share on Twitter Share on Facebook Share on Linkedin

FDA announces recall of hypertension medications due to potential cancer risk

Share on Twitter Share on Facebook Share on Linkedin
These quinapril HCl/hydrochlorothiazide tablets, which Pfizer sells under the name Accuretic, are included in the voluntary FDA recall.
The voluntary recall includes quinapril HCl/hydrochlorothiazide tablets sold by Pfizer and authorized generics of that same medication. 
READ MORE >

Bariatric surgery associated with lower risk of death and cardiovascular disease

Researchers examined data from 39 different studies, focusing on mortality rates and adverse cardiovascular outcomes. 

READ MORE >
Cleveland Clinic Bariatric
Share on Twitter Share on Facebook Share on Linkedin

Bariatric surgery associated with lower risk of death and cardiovascular disease

Share on Twitter Share on Facebook Share on Linkedin
Cleveland Clinic Bariatric
Researchers examined data from 39 different studies, focusing on mortality rates and adverse cardiovascular outcomes. 
READ MORE >

Long-term use of angiotensin-receptor blockers increases risk of cancer, new study confirms

These findings have “profound implications for patients and prescribing clinicians," one researcher said. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Long-term use of angiotensin-receptor blockers increases risk of cancer, new study confirms

Share on Twitter Share on Facebook Share on Linkedin
These findings have “profound implications for patients and prescribing clinicians," one researcher said. 
READ MORE >

Losartan fails to improve lung injuries in hospitalized COVID-19 patients

Some of the study's findings even raised concerns that losartan could be harming these patients. 

READ MORE >
Nurses caring for a COVID-19 patient in the COVID unit at Banner University Medical Center in Phoenix.
Share on Twitter Share on Facebook Share on Linkedin

Losartan fails to improve lung injuries in hospitalized COVID-19 patients

Share on Twitter Share on Facebook Share on Linkedin
Nurses caring for a COVID-19 patient in the COVID unit at Banner University Medical Center in Phoenix.
Some of the study's findings even raised concerns that losartan could be harming these patients. 
READ MORE >

Drinking wine with meals may lower risk of type 2 diabetes

The same benefit was not seen, however, when alcohol was consumed without food.

READ MORE >
A new study shows drinking a moderate amount of alcohol with meals is associated with a lower overall risk of developing type 2 diabetes.
Share on Twitter Share on Facebook Share on Linkedin

Drinking wine with meals may lower risk of type 2 diabetes

Share on Twitter Share on Facebook Share on Linkedin
A new study shows drinking a moderate amount of alcohol with meals is associated with a lower overall risk of developing type 2 diabetes.
The same benefit was not seen, however, when alcohol was consumed without food.
READ MORE >

Verapamil shows potential as a long-term oral treatment for type 1 diabetes

Much more research is still required — but could verapamil be the first oral medication for type 1 diabetes? 

READ MORE >
diabetes
Share on Twitter Share on Facebook Share on Linkedin

Verapamil shows potential as a long-term oral treatment for type 1 diabetes

Share on Twitter Share on Facebook Share on Linkedin
diabetes
Much more research is still required — but could verapamil be the first oral medication for type 1 diabetes? 
READ MORE >

Hypertension patients benefit from new intervention focused on education, motivation and text messages

Improving the way we communicate with ED patients about their blood pressure could make a significant long-term impact on their health. 

READ MORE >
American Heart Association and Joint Commission launch new Comprehensive Heart Attack Center certification.
Share on Twitter Share on Facebook Share on Linkedin

Hypertension patients benefit from new intervention focused on education, motivation and text messages

Share on Twitter Share on Facebook Share on Linkedin
American Heart Association and Joint Commission launch new Comprehensive Heart Attack Center certification.
Improving the way we communicate with ED patients about their blood pressure could make a significant long-term impact on their health. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
M&A activity in cardiology: Exploring key trends | Cardiac PET vs. SPECT | Doctors support Medicare covering TAVR for AR
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme